Addus Homecare Corp SEC Filings

Addus HomeCare Corp. (ADUS) Form 144 notifies a proposed sale of 25,000 common shares by an identified seller through Morgan Stanley Smith Barney on Nasdaq with an aggregate market value of $2,895,722.50. The shares were acquired and are proposed to be sold on 09/02/2025 following a stock option exercise paid in cash. The filer also discloses a prior sale by the same person of 25,000 shares on 08/20/2025 for gross proceeds of $2,873,862.50. The notice includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.

Addus HomeCare Corporation filed a Form S-3 shelf registration to register an indeterminate maximum aggregate amount of common stock, preferred stock, warrants and units for offer and sale from time to time after the effective date as a well-known seasoned issuer.

The prospectus permits concurrent resale by selling stockholders to be named in any prospectus supplement and states that any proceeds from sales by selling stockholders will not be received by the company unless an applicable prospectus supplement indicates otherwise. As of August 20, 2025, the company had 40,000,000 shares of common stock authorized and 18,432,157 shares of common stock outstanding.

Addus HomeCare Corporation amended its Current Report to provide additional financial disclosure related to a completed acquisition. The company reports that on December 2, 2024 its subsidiary, Addus HealthCare, Inc., completed the acquisition of the personal care business of Curo Health Services, LLC (doing business as Gentiva). This Amendment No. 2 adds unaudited financial statements of the acquired business for the year-to-date ended December 1, 2024, and references an unaudited pro forma condensed combined statement of operations for the same period filed as Exhibit 99.1. The filing states that all other disclosures in the prior amended report remain unchanged.

Addus HomeCare Corporation amended its Current Report to provide additional financial disclosure related to a completed acquisition. The company reports that on December 2, 2024 its subsidiary, Addus HealthCare, Inc., completed the acquisition of the personal care business of Curo Health Services, LLC (doing business as Gentiva). This Amendment No. 2 adds unaudited financial statements of the acquired business for the year-to-date ended December 1, 2024, and references an unaudited pro forma condensed combined statement of operations for the same period filed as Exhibit 99.1. The filing states that all other disclosures in the prior amended report remain unchanged.

Addus HomeCare Corp. (ADUS) insider filing: Brian Poff, EVP and Chief Financial Officer, reported sales of company common stock on 08/25/2025. He sold 4,106 shares at a weighted-average price of $116.55 (sales ranged $115.76–$116.73) and 3,633 shares at a weighted-average price of $117.13 (sales ranged $116.78–$117.43). After these transactions he beneficially owned 56,980 shares. The Form 4 is signed by Mr. Poff on 08/26/2025 and discloses that the shares were sold in multiple transactions; the filer offers to provide detailed per-price quantities on request.

Addus HomeCare Corp. (ADUS) Form 144 notifies the proposed sale of 7,739 common shares through Morgan Stanley Smith Barney on 08/25/2025 on NASDAQ with an aggregate market value of $904,114.87. The filing shows 18,407,239 shares outstanding. The shares to be sold were recently acquired as restricted stock from the issuer on 02/22/2025 (2,792 shares), 02/23/2025 (1,881 shares) and 02/24/2025 (3,066 shares), with payment noted as Not Applicable. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Allison R. Dirk, Chairman and CEO of Addus HomeCare Corp. (ADUS), reported option exercise and stock sales on 08/20/2025. She exercised 25,000 employee stock options with a $19.71 exercise price, resulting in ownership of 25,000 shares from that exercise. On the same date she sold a total of 25,000 common shares in two blocks: 17,560 shares at a weighted average price of $114.71 and 7,440 shares at a weighted average price of $115.53. After these transactions her beneficial ownership is reported as 166,461 shares. The filing notes all options were fully vested and sale price ranges are provided in footnotes.

Form 4: Veronica Hill-Milbourne, a director of Addus HomeCare Corp. (ADUS), sold 1,571 shares of common stock on 08/19/2025 at a reported price of $114.93 per share, reducing her direct beneficial ownership to 5,067 shares. The filing was signed by an attorney-in-fact on 08/21/2025. This report discloses an insider sale and the remaining direct ownership stake held by the reporting person.

Addus HomeCare Corp. (ADUS) submitted a Form 144 disclosing a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney LLC, scheduled for 08/20/2025. The filing shows the shares were acquired and paid for on 08/20/2025 via a stock option exercise with cash payment. The aggregate market value of the shares at filing is $2,873,862.50 and the company reports 18,407,239 shares outstanding. The filer reports no sales of the issuer’s securities in the past three months and includes the standard Rule 144 representation regarding possession of material nonpublic information.

Addus HomeCare Corp. (ADUS) filing a Form 144 notifies the proposed sale of 1,571 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $180,555.03 and an approximate sale date of 08/19/2025 on NASDAQ. The filer reports total outstanding shares of 18,407,239. The shares were acquired as restricted stock in three tranches: 1,013 on 06/12/2025, 104 on 06/16/2022, and 454 on 06/15/2021. The filing contains no reported sales in the past three months and includes the standard attestation about material nonpublic information.